Dangerous Prescription Drugs News

Testosterone Products and Supplements

New Study Favors Testosterone Therapy, Fails to Look at Low T Products

A recently released study shows that the injectable form of low testosterone drugs do not increase the risk of a heart attack in older men. The study is being touted by companies that make so-called “Low-T” products, but it failed to address the more popular forms of this drug – like gels and pills – […]

Jul 9, 2014 Read More...

man working in lab with test tubes

New Studies Shed Light on Testosterone Therapy

Exercise, obesity and infertility are the major topics in the latest news on testosterone replacement therapy (TRT). Studies presented at the recent American Urological Association (AUA) meeting show that exercise improves the effect of testosterone therapy, while obesity reduces the success rate. One of the three studies on obesity showed that it actually could be […]

Jun 11, 2014 Read More...

Clarus Therapeutics Logo

Clarus Therapeutics Plans IPO, Oral Testosterone Drug

Amid the ongoing controversy over the safety of testosterone therapy, the maker of a new medication for low testosterone (Low T) plans an $86.2 million initial public offering (IPO) later this year. Clarus Therapeutics hopes to have its oral testosterone drug, Rextoro, to the Food and Drug Administration (FDA) for review by November. This marks […]

Jun 2, 2014 Read More...

men and women and hormone replacement

Men and Women Face Risks from Hormone Replacement Therapy

In 1966, Dr. Robert A. Wilson, a gynecologist, decided menopause was no longer a normal stage of life. “No woman can be sure of escaping the horror of this living decay,” he wrote in the popular book “Feminine Forever.” “There is no need for either valor or pretense. The need is for hormones.” Decades later, […]

May 15, 2014 Read More...

diabetes drugs, blood sugar meter

Side Effects Soar for Newer Classes of Diabetes Drugs

A list of the newer classes of Type 2 diabetes drugs reads like alphabet soup: GLP-1, DPP-4, SLGT2. But the list of possible side effects carries a much more somber tone: pancreatitis, pancreatic cancer, urinary infections, thyroid cancer, gastrointestinal issues, and renal and gallbladder problems. In a groundbreaking report, AdverseEvents (AE), a California-based company that […]

May 12, 2014 Read More...

Black Box Warning on Testosterone Pills

Advocacy Groups: Testosterone Products Need Black-Box Warning About Heart Attack Risk

Despite a growing number of studies pointing to increased heart attack risk with testosterone replacement therapy drugs, the U.S. Food and Drug Administration (FDA) has yet to require warning labels on testosterone products. Drug companies, including AbbVie Inc., which manufactures AndroGel, are marketing their testosterone replacement drugs aggressively to treat “Low T” – a low […]

Apr 1, 2014 Read More...

Loading